Achievements in R&D

News & Achievements

Proudly Recognized by DSIR
Advancing Pharma Innovation at Mendine

DSIR Accreditation Announcement – November 17, 2025

Leadership Message

Mr. Probhas Bondhu Chakraborty

Managing Director

We are thrilled to announce that Mendine Pharmaceuticals Pvt Ltd's in-house R&D unit has been officially recognized by the Department of Scientific and Industrial Research (DSIR), Government of India, effective November 17, 2025.

This accreditation validates our commitment to pioneering research in pharmaceutical formulations and innovative processes that contribute to advancing healthcare solutions.

“This recognition fuels our vision for innovative, patient-centric pharmaceutical solutions and strengthens Mendine’s role in shaping the future of pharmaceutical research in Eastern India.”

Strategic Edge

Dr. Amitava Kabiraj – HOD R&D

As an MSME manufacturing unit, Mendine exemplifies agility by integrating cutting-edge R&D such as formulation innovation and process optimization directly with production lines.

This synergy enables faster innovation, import substitution, and quality enhancements — a rare capability among MSMEs in eastern India.

This accreditation also unlocks tax benefits, funding access, and research partnership opportunities, amplifying Mendine's role as an innovation leader in the pharmaceutical sector.

Key Benefits of DSIR Accreditation

Eligibility for customs duty exemptions on R&D imports
Access to weighted tax deductions
Enhanced credibility for collaborations and research grants
Strengthened intellectual property development
Facilitated technology transfer and industry partnerships

Download Certificate